Rifampicin Loaded in Alginate/chitosan Nanoparticles As a Promising Pulmonary Carrier Against Staphylococcus Aureus

Overview

Journal Drug Deliv Transl Res

Publisher Springer

Specialty Pharmacology

Date 2020 May 5

PMID 32363536

Citations 21

Authors

I R Scolari

P L Paez

M M Musri

J P Petiti

A Torres

G E Granero

Affiliations

Soon will be listed here.

Abstract

This study aims to explore the antimicrobial activity of rifampicin (RIF) and ascorbic acid (ASC) co-loaded into alginate (ALG)/chitosan (CS) nanoparticles (RIF/ASC NPs) and tested for their antibacterial activity against several strains of methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). Also, the present research focused on exploring the possible antibacterial mechanism of action of these RIF/ASC NPs, which demonstrated a significant biocide activity against the S. aureus strains with minimum inhibitory concentrations (MIC) between 2- and 8-fold lower than those one exhibited with the free antibiotic RIF. The proposed antimicrobial mechanism of action of the RIF/ASC NPs seems to be the result of collaborative effects between NPs and the RIF/ASC antibiotic combination. Moreover, results indicated that the functionalized RIF/ASC NP surface played a crucial role on the processes of NP adhesion into the bacterial surface, the alterations on the cell membrane integrity, and the cell uptake of the RIF/ASC antibiotic into bacteria. Further, the in vivo lung deposition pattern of empty NPs labeled (NPs-FITC) with isothiocyanate fluorescein in rats was investigated post intratracheal instillation of NPs. In summary, findings from this work show that our novel designed engineered RIF/ASC co-loaded NPs could be a suitable system for antibiotic lung administration with promising perspectives for effective treatments of pulmonary intracellular infections for those known antibiotics that are losing effectiveness due to antimicrobial resistance problems. Graphical Abstract.

Citing Articles

Nanoparticles as Drug Delivery Vehicles for People with Cystic Fibrosis.

Hourihane E, Hixon K Biomimetics (Basel). 2024; 9(9).

PMID: 39329596 PMC: 11430251. DOI: 10.3390/biomimetics9090574.

Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications.

Uzokboev S, Akhmadbekov K, Nuritdinova R, Tawfik S, Lee Y Beilstein J Nanotechnol. 2024; 15:1077-1104.

PMID: 39188756 PMC: 11346306. DOI: 10.3762/bjnano.15.88.

Research and Application of Chitosan Nanoparticles in Orthopedic Infections.

Shi S, Shi W, Zhou B, Qiu S Int J Nanomedicine. 2024; 19:6589-6602.

PMID: 38979535 PMC: 11228078. DOI: 10.2147/IJN.S468848.

Chitosan/Alginate-Based Nanoparticles for Antibacterial Agents Delivery.

Wathoni N, Herdiana Y, Suhandi C, Mohammed A, El-Rayyes A, Narsa A Int J Nanomedicine. 2024; 19:5021-5044.

PMID: 38832335 PMC: 11146614. DOI: 10.2147/IJN.S469572.

Newly designed nanoparticle-drug delivery systems against infection: a systematic review.

Kamarehei F, Saleh G, Hemmati J, Gohari S Int J Clin Exp Pathol. 2024; 17(4):96-107.

PMID: 38716352 PMC: 11070434. DOI: 10.62347/BVWH1940.

References

Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S . The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015; 6:22-9. PMC: 4446399. DOI: 10.1016/j.nmni.2015.02.007. View

Assis L, Nedeljkovic M, Dessen A . New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. Drug Resist Updat. 2017; 31:1-14. DOI: 10.1016/j.drup.2017.03.001. View

Gao W, Chen Y, Zhang Y, Zhang Q, Zhang L . Nanoparticle-based local antimicrobial drug delivery. Adv Drug Deliv Rev. 2017; 127:46-57. PMC: 5860926. DOI: 10.1016/j.addr.2017.09.015. View

Sarkar N, Sahoo G, Das R, Prusty G, Swain S . Carbon quantum dot tailored calcium alginate hydrogel for pH responsive controlled delivery of vancomycin. Eur J Pharm Sci. 2017; 109:359-371. DOI: 10.1016/j.ejps.2017.08.015. View

Sorasitthiyanukarn F, Ratnatilaka Na Bhuket P, Muangnoi C, Rojsitthisak P, Rojsitthisak P . Chitosan/alginate nanoparticles as a promising carrier of novel curcumin diethyl diglutarate. Int J Biol Macromol. 2019; 131:1125-1136. DOI: 10.1016/j.ijbiomac.2019.03.120. View

Rajaram S, Vemuri V, Natham R . Ascorbic acid improves stability and pharmacokinetics of rifampicin in the presence of isoniazid. J Pharm Biomed Anal. 2014; 100:103-108. DOI: 10.1016/j.jpba.2014.07.027. View

Hartmann M, Berditsch M, Hawecker J, Ardakani M, Gerthsen D, Ulrich A . Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob Agents Chemother. 2010; 54(8):3132-42. PMC: 2916356. DOI: 10.1128/AAC.00124-10. View

Radovic-Moreno A, Lu T, Puscasu V, Yoon C, Langer R, Farokhzad O . Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012; 6(5):4279-87. PMC: 3779925. DOI: 10.1021/nn3008383. View

Hoppens M, Sylvester C, Qureshi A, Scherr T, Czapski D, Duran R . Ceragenin mediated selectivity of antimicrobial silver nanoparticles. ACS Appl Mater Interfaces. 2014; 6(16):13900-8. DOI: 10.1021/am504640f. View

10.

Yuan C, Wang X, Gao X, Chen F, Liang X, Li D . Effects of surface properties of polymer-based restorative materials on early adhesion of Streptococcus mutans in vitro. J Dent. 2016; 54:33-40. DOI: 10.1016/j.jdent.2016.07.010. View

11.

Carson C, Mee B, Riley T . Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother. 2002; 46(6):1914-20. PMC: 127210. DOI: 10.1128/AAC.46.6.1914-1920.2002. View

12.

Ferreira C, Pereira A, Pereira M, Melo L, Simoes M . Physiological changes induced by the quaternary ammonium compound benzyldimethyldodecylammonium chloride on Pseudomonas fluorescens. J Antimicrob Chemother. 2011; 66(5):1036-43. DOI: 10.1093/jac/dkr028. View

13.

Geisberger G, Gyenge E, Hinger D, Kach A, Maake C, Patzke G . Chitosan-thioglycolic acid as a versatile antimicrobial agent. Biomacromolecules. 2013; 14(4):1010-7. DOI: 10.1021/bm3018593. View

14.

Vasileva-Tonkova E, Galabova D, Karpenko E, Shulga A . Biosurfactant-rhamnolipid effects on yeast cells. Lett Appl Microbiol. 2001; 33(4):280-4. DOI: 10.1046/j.1472-765x.2001.00996.x. View

15.

Sana S, Datta S, Biswas D, Sengupta D . Assessment of synergistic antibacterial activity of combined biosurfactants revealed by bacterial cell envelop damage. Biochim Biophys Acta Biomembr. 2017; 1860(2):579-585. DOI: 10.1016/j.bbamem.2017.09.027. View

16.

Remichkova M, Galabova D, Roeva I, Karpenko E, Shulga A, Galabov A . Anti-herpesvirus activities of Pseudomonas sp. S-17 rhamnolipid and its complex with alginate. Z Naturforsch C J Biosci. 2008; 63(1-2):75-81. DOI: 10.1515/znc-2008-1-214. View